As described previously24, a significant delay in tumour growth was observed in WT mice injected with OT-I - suggesting that effective OT-I CD8+ T cell priming is mediated by DCs through cross-presentation (Fig. 2a). This evidence concerns the gene CD8A and neoplasm.